Selenomethionine and selenocysteine double labeling strategy for crystallographic phasing

Structure

Volumn 11, Issue 11, 2003, Pages 1359-1367

  Strub, Marie Paule ^a   Hoh, François ^a   Sanchez, Jean Frédéric ^a   Strub, Jean Marc ^b   Böck, August ^c   Aumelas, André ^a   Dumas, Christian ^a  

^a CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELIN; NUCLEOSIDE DIPHOSPHATE KINASE; PROTEGRIN; RECOMBINANT PROTEIN; SELENOCYSTEINE; SELENOMETHIONINE;

ARTICLE; CONTROLLED STUDY; DISULFIDE BOND; ENZYME STRUCTURE; ESCHERICHIA COLI; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0242710958     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2003.09.014     Document Type: Article

References (56)

1. Altamirano M.M., Garcia C., Possani L.D., Fersht A.R. Oxidative refolding chromatography. folding of the scorpion toxin Cn5 Nat. Biotechnol. 17:1999;187-191.
2. Arner E.S., Sarioglu H., Lottspeich F., Holmgren A., Böck A. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. J. Mol. Biol. 292:1999;1003-1016.
3. Bae J.H., Alefelder S., Kaiser J.T., Friedrich R., Moroder L., Huber R., Budisa N. Incorporation of beta-selenolo[3,2-b]pyrrolyl-alanine into proteins for phase determination in protein X-ray crystallography. J. Mol. Biol. 309:2001;925-936.
4. Bairoch A., Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res. 28:2000;45-48.
5. Bellizzi J.J., Widom J., Kemp C.W., Clardy J. Producing selenomethionine-labeled proteins with a baculovirus expression vector system. Struct. Fold. Des. 7:1999;R263-R267.
6. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 28:2000;235-242.
7. Besse D., Budisa N., Karnbrock W., Minks C., Musiol H.J., Pegoraro S., Siedler F., Weyher E., Moroder L. Chalcogen-analogs of amino acids. Their use in X-ray crystallographic and folding studies of peptides and proteins. Biol. Chem. 378:1997;211-218.
8. Böck A., Forchhammer K., Heider J., Baron C. Selenoprotein synthesis. an expansion of the genetic code Trends Biochem. Sci. 16:1991;463-467.
9. Boggon T.J., Shapiro L. Screening for phasing atoms in protein crystallography. Struct. Fold. Des. 8:2000;R143-R149.
10. Boschi-Muller S., Muller S., Van Dorsselaer A., Böck A., Branlant G. Substituting selenocysteine for active site cysteine 149 of phosphorylating glyceraldehyde 3-phosphate dehydrogenase reveals a peroxidase activity. FEBS Lett. 439:1998;241-245.
11. Budisa N., Steipe B., Demange P., Eckerskorn C., Kellermann J., Huber R. High-level biosynthetic substitution of methionine in proteins by its analogs 2-aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur. J. Biochem. 230:1995;788-796.
12. Budisa N., Karnbrock W., Steinbacher S., Humm A., Prade L., Neuefeind T., Moroder L., Huber R. Bioincorporation of telluromethionine into proteins. a promising new approach for X-ray structure analysis of proteins J. Mol. Biol. 270:1997;616-623.
13. Bushnell D.A., Cramer P., Kornberg R.D. Selenomethionine incorporation in Saccharomyces cerevisiae RNA polymerase II. Structure. 9:2001;R11-R14.
14. CCP4 The CCP. 4(Collaborative Computational Project 4suite: programs for protein crystallography):1994;. D 50, 760-763.Acta Crystallogr.
15. Chen W., Bahl O.P. Recombinant carbohydrate and selenomethionyl variants of human choriogonadotropin. J. Biol. Chem. 266:1991;8192-8197.
16. Cowie D.B., Cohen G.N. Biosynthesis by E. coli of active proteins containing selenium instead of sulphur. Biochim. Biophys. Acta. 26:1957;252-261.
17. Cowtan K.D., Zhang K.Y. Density modification for macromolecular phase improvement. Prog. Biophys. Mol. Biol. 72:1999;245-270.
18. Dauter Z. New approaches to high-throughput phasing. Curr. Opin. Struct. Biol. 12:2002;674-678.
19. Dauter Z., Adamiak D.A. Anomalous signal of phosphorus used for phasing DNA oligomer. importance of data redundancy Acta Crystallogr. D. 57:2001;990-995.
20. Dauter Z., Dauter M., de La Fortelle E., Bricogne G., Sheldrick G.M. Can anomalous signal of sulfur become a tool for solving protein crystal structures? J. Mol. Biol. 289:1999;83-92.
21. Dauter Z., Dauter M., Dodson E. Jolly SAD. Acta Crystallogr. D. 58:2002;494-506.
22. de La Fortelle E., Bricogne G. Maximum-likelihood heavy atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276:1997;472-494.
23. Deacon A.M., Ealick S.E. Selenium-based MAD phasing. setting the sites on larger structures Struct. Fold. Des. 7:1999;R161-R166.
24. Debreczeni J.E., Bunkoczi G., Ma Q., Blaser H., Sheldrick G.M. In-house measurement of the sulfur anomalous signal and its use for phasing. Acta Crystallogr. D. 59:2003;688-696.
25. Doublié S. Preparation of selenomethionyl proteins for phase determination. Methods Enzymol. 276:1997;523-530.
26. Dumas C., Lascu I., Morera S., Glaser P., Fourme R., Wallet V., Lacombe M.L., Véron M., Janin J. X-ray structure of nucleoside diphosphate kinase. EMBO J. 11:1992;3203-3208.
27. Ealick S.E. Advances in multiple wavelength anomalous diffraction crystallography. Curr. Opin. Chem. Biol. 4:2000;495-499.
28. Hendrickson W.A. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science. 254:1991;51-58.
29. Hendrickson W. Maturation of MAD phasing for the determination of macromolecular structures. J. Synchroton. Radiat. 6:1999;845-851.
30. Hendrickson W.A., Ogata C.M. Phase determination from multiwavelength anomalous diffraction measurements. Methods Enzymol. 276:1997;494-523.
31. Hendrickson W.A., Teeter M.M. Structure of the hydrophobic protein crambin determined directly from the anomalous scattering of sulfur. Nature. 290:1981;107-113.
32. Hendrickson W.A., Horton J.R., LeMaster D.M. Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD). a vehicle for direct determination of three-dimensional structure EMBO J. 9:1990;1665-1672.
33. Kigawa T., Yamaguchi-Nunokawa E., Kodama K., Matsuda T., Yabuki T., Matsuda N., Ishitani R., Nureki O., Yokoyama S. Selenomethionine incorporation into a protein by cell-free synthesis. J. Struct. Funct. Genomics. 2:2002;29-35.
34. Larsson A.M., Stahlberg J., Jones T.A. Preparation and crystallization of selenomethionyl dextranase from Penicillium minioluteum expressed in Pichia pastoris. Acta Crystallogr. D. 58:2002;346-348.
35. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck. a program to check the stereochemistry quality of protein structures J. Appl. Crystallogr. 26:1993;283-291.
36. Lemke C.T., Smith G.D., Howell P.L. S-SAD, Se-SAD and S/Se-SIRAS using Cu Kalpha radiation. why wait for synchrotron time? Acta Crystallogr. D. 58:2002;2096-2101.
37. Lustbader J.W., Wu H., Birken S., Pollak S., Gawinowicz Kolks M.A., Pound A.M., Austen D., Hendrickson W.A., Canfield R.E. The expression, characterization, and crystallization of wild-type and selenomethionyl human chorionic gonadotropin. Endocrinology. 136:1995;640-650.
38. Micossi E., Hunter W.N., Leonard G.A. De novo phasing of two crystal forms of tryparedoxin II using the anomalous scattering from S atoms. a combination of small signal and medium resolution reveals this to be a general tool for solving protein crystal structures Acta Crystallogr. D. 58:2002;21-28.
39. Morera S., Lascu I., Dumas C., LeBras G., Briozzo P., Veron M., Janin J. Adenosine 5′-diphosphate binding and the active site of nucleoside diphosphate kinase. Biochemistry. 33:1994;459-467.
40. Müller S., Senn H., Gsell B., Vetter W., Baron C., Böck A. The formation of diselenide bridges in proteins by incorporation of selenocysteine residues. biosynthesis and characterization of (Se)2-thioredoxin Biochemistry. 33:1994;3404-3412.
41. Murshudov G.N., Vagin A.A., Lebedev A., Wilson K.S., Dodson E.J. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D. 55:1999;247-255.
42. Otwinowski Z., Minor W. Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-325.
43. Pegoraro S., Fiori S., Rudolph-Bohner S., Watanabe T.X., Moroder L. Isomorphous replacement of cystine with selenocystine in endothelin. oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]- endothelin-1 J. Mol. Biol. 284:1998;779-792.
44. Pegoraro S., Fiori S., Cramer J., Rudolph-Bohner S., Moroder L. The disulfide-coupled folding pathway of apamin as derived from diselenide-quenched analogs and intermediates. Protein Sci. 8:1999;1605-1613.
45. Rice L.M., Earnest T.N., Brunger A.T. Single-wavelength anomalous diffraction phasing revisited. Acta Crystallogr. D. 56:2000;1413-1420.
46. Roth M., Carpentier P., Kaikati O., Joly J., Charrault P., Pirocchi M., Kahn R., Fanchon E., Jacquamet L., Borel F.et al. Fip. a highly automated beamline for multiwavelength anomalous diffraction experiments Acta Crystallogr. D. 58:2002;805-814.
47. Rudenko G., Nguyen T., Chelliah Y., Sudhof T.C., Deisenhofer J. The structure of the ligand-binding domain of neurexin Ibeta. regulation of LNS domain function by alternative splicing Cell. 99:1999;93-101.
48. Sanchez J.F., Hoh F., Strub M.P., Aumelas A., Dumas C. Structure of the cathelicidin motif of protegrin-3 precursor. structural insights into the activation mechanism of an antimicrobial protein Structure. 10:2002;1363-1370. a.
49. Sanchez J.F., Wojcik F., Yang Y.S., Strub M.P., Strub J.M., Van Dorsselaer A., Martin M., Lehrer R., Ganz T., Chavanieu A.et al. Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor. Biochemistry. 41:2002;21-30. b.
50. Smith J.L., Thompson A. Reactivity of selenomethionine-dents in the magic bullet? Structure. 6:1998;815-819.
51. Stadtman T.C. Selenocysteine. Annu. Rev. Biochem. 65:1996;83-100.
52. Tesmer J.J., Klem T.J., Deras M.L., Davisson V.J., Smith J.L. The crystal structure of GMP synthetase reveals a novel catalytic triad and is a structural paradigm for two enzyme families. Nat. Struct. Biol. 3:1996;74-86.
53. Thomazeau K., Curien G., Thompson A., Dumas R., Biou V. MAD on threonine synthase. the phasing power of oxidized selenomethionine Acta Crystallogr. D. 57:2001;1337-1340.
54. Van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., Clardy J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J. Mol. Biol. 229:1993;105-124.
55. Wu H., Lustbader J.W., Liu Y., Canfield R.E., Hendrickson W.A. Structure of human chorionic gonadotropin at 2.6 Å resolution from MAD analysis of the selenomethionyl protein. Structure. 2:1994;545-558.
56. Xu B., Munoz I.I., Janson J.C., Stahlberg J. Crystallization and X-ray analysis of native and selenomethionyl beta-mannanase Man5A from blue mussel, Mytilus edulis, expressed in Pichia pastoris. Acta Crystallogr. D. 58:2002;542-545.